Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Design of enzyme inhibitors using iterative protein crystallographic analysis.

× No keyword cloud information.

23 in total

1. Functional group placement in protein binding sites: a comparison of GRID and MCSS.

Authors: R Bitetti-Putzer; D Joseph-McCarthy; J M Hogle; M Karplus
Journal: J Comput Aided Mol Des Date: 2001-10 Impact factor: 3.686

2. Hypoxanthine phosphoribosyltransferase from Trypanosoma cruzi as a target for structure-based inhibitor design: crystallization and inhibition studies with purine analogs.

Authors: A E Eakin; A Guerra; P J Focia; J Torres-Martinez; S P Craig
Journal: Antimicrob Agents Chemother Date: 1997-08 Impact factor: 5.191

3. Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors.

Authors: S E Ealick; Y S Babu; C E Bugg; M D Erion; W C Guida; J A Montgomery; J A Secrist
Journal: Proc Natl Acad Sci U S A Date: 1991-12-15 Impact factor: 11.205

4. NMR structure-based drug design.

Authors: S W Fesik
Journal: J Biomol NMR Date: 1993-05 Impact factor: 2.835

Review 5. Resistance to human immunodeficiency virus type 1 protease inhibitors.

Authors: D Boden; M Markowitz
Journal: Antimicrob Agents Chemother Date: 1998-11 Impact factor: 5.191

Review 6. Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs.

Authors: H J Böhm
Journal: J Comput Aided Mol Des Date: 1998-07 Impact factor: 3.686

Design of enzyme inhibitors using iterative protein crystallographic analysis.

1. Functional group placement in protein binding sites: a comparison of GRID and MCSS.

2. Hypoxanthine phosphoribosyltransferase from Trypanosoma cruzi as a target for structure-based inhibitor design: crystallization and inhibition studies with purine analogs.

3. Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors.

4. NMR structure-based drug design.

Review 5. Resistance to human immunodeficiency virus type 1 protease inhibitors.

Review 6. Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs.

7. The statistical-thermodynamic basis for computation of binding affinities: a critical review.

8. Protein structure from x-ray diffraction.

9. Regulation of p53 expression by thymidylate synthase.

10. BUILDER v.2: improving the chemistry of a de novo design strategy.